PT2459175T - Novo processo de granulação e o granulado assim preparado - Google Patents

Novo processo de granulação e o granulado assim preparado

Info

Publication number
PT2459175T
PT2459175T PT107153389T PT10715338T PT2459175T PT 2459175 T PT2459175 T PT 2459175T PT 107153389 T PT107153389 T PT 107153389T PT 10715338 T PT10715338 T PT 10715338T PT 2459175 T PT2459175 T PT 2459175T
Authority
PT
Portugal
Prior art keywords
granulating process
prepared granulate
new granulating
new
granulate
Prior art date
Application number
PT107153389T
Other languages
English (en)
Inventor
Tölgyesi Zoltán
Zsigmond Zsolt
Újfalussy György
Leventiszné Huszár Magdolna
Tonka-Nagy Péter
Agyagos Mónika
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU0900468A external-priority patent/HU0900468D0/hu
Priority claimed from HU1000044A external-priority patent/HU230900B1/hu
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of PT2459175T publication Critical patent/PT2459175T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT107153389T 2009-07-28 2010-02-24 Novo processo de granulação e o granulado assim preparado PT2459175T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0900468A HU0900468D0 (en) 2009-07-28 2009-07-28 Novel granulation process and granulates therefrom
HU1000044A HU230900B1 (en) 2010-01-25 2010-01-25 New granulating process and the granulates prepared by this

Publications (1)

Publication Number Publication Date
PT2459175T true PT2459175T (pt) 2018-02-07

Family

ID=89989520

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107153389T PT2459175T (pt) 2009-07-28 2010-02-24 Novo processo de granulação e o granulado assim preparado

Country Status (10)

Country Link
US (1) US8927021B2 (pt)
EP (1) EP2459175B1 (pt)
BR (1) BR112012002069B8 (pt)
EA (1) EA027578B1 (pt)
ES (1) ES2657708T3 (pt)
HU (1) HUE038048T2 (pt)
PL (1) PL2459175T3 (pt)
PT (1) PT2459175T (pt)
WO (1) WO2011012912A2 (pt)
ZA (1) ZA201200795B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU231036B1 (hu) * 2013-09-30 2019-12-30 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Koleszterin bioszintézis gátló hatóanyagot és koleszterin abszorpciót gátló hatóanyagot tartalmazó kombinációs gyógyszerkészítmény
KR101977785B1 (ko) * 2014-06-25 2019-05-14 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 및 그 제조방법
EP3243506A1 (en) * 2016-05-09 2017-11-15 Adamed sp. z o.o. Pharmaceutical composition
CZ2016538A3 (cs) * 2016-09-05 2018-03-14 Zentiva, K.S. Farmaceutická kompozice obsahující dvě rozdílné účinné látky
CZ2016539A3 (cs) * 2016-09-05 2018-03-14 Zentiva, K.S. Farmaceutická kompozice obsahující dvě rozdílné účinné látky a způsob její přípravy
US20180338922A1 (en) 2017-05-26 2018-11-29 Esperion Therapeutics, Inc. Fixed dose formulations
GR1010183B (el) * 2020-12-14 2022-03-01 Elpen Αε Φαρμακευτικη Βιομηχανια, Στερεες φαρμακοτεχνικες μορφες ατορβαστατινης και εζετιμιμπης

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060160785A1 (en) 2004-12-03 2006-07-20 Judith Aronhime Ezetimibe polymorphs
AU2008337435A1 (en) * 2007-12-17 2009-06-25 Krka, Tovarna Zdravil, D.D., Novo Mesto Suspension comprising non-micronized ezetimibe micro-particles

Also Published As

Publication number Publication date
WO2011012912A2 (en) 2011-02-03
US8927021B2 (en) 2015-01-06
EP2459175B1 (en) 2017-11-01
EA201290055A1 (ru) 2012-06-29
PL2459175T3 (pl) 2018-04-30
ZA201200795B (en) 2013-05-29
BR112012002069A2 (pt) 2016-05-31
EA027578B1 (ru) 2017-08-31
EP2459175A2 (en) 2012-06-06
WO2011012912A3 (en) 2011-12-08
BR112012002069B8 (pt) 2021-05-25
ES2657708T3 (es) 2018-03-06
US20120164227A1 (en) 2012-06-28
HUE038048T2 (hu) 2018-09-28
BR112012002069B1 (pt) 2020-12-01

Similar Documents

Publication Publication Date Title
PL2309987T3 (pl) Granulacja metodą stapiania
SI2459531T1 (sl) Granulat, ki obsega vildagliptin, in postopek njegove priprave
EP2518014A4 (en) CARBON MICROPARTICLES AND MANUFACTURING METHOD THEREFOR
PL2249961T3 (pl) Granulat środka adsorpcyjnego i sposób jego wytwarzania
EP2623542A4 (en) POLYMER MICROPARTICLES AND PROCESS FOR PRODUCING THE SAME
ZA201101123B (en) Nicotine-containing granulate
HK1169280A1 (en) Carnitine granulate and methods for its production
GB201001544D0 (en) Pellets and process therefor
EP2524935A4 (en) POLYMER WITH OPENED CYCLOPIANE RING AND METHOD OF MANUFACTURING THEREOF
PL2576477T3 (pl) Granulowany pumeks i sposób jego wytwarzania
ZA201200795B (en) New granulating process and thus prepared granulate
GB201122246D0 (en) Catalyst and process
EP2471756A4 (en) METHOD FOR PRODUCING FLAKES AND METHOD FOR PRODUCING GLASS PRODUCT
EP2651994A4 (en) AMPHOTHERO POLYMER AND METHOD FOR PRODUCING THE SAME
EP2300140A4 (en) DEVICE AND METHOD FOR GRANULATING SULFUR
EP2310130A4 (en) GRINDER MILL
PL2475455T3 (pl) Sposób wytwarzania granulek
EP2475246A4 (en) MICROCAPSEL AND MANUFACTURING METHOD THEREFOR
PL2164619T3 (pl) Sposób granulowania i urządzenie
EP2578725A4 (en) COATED ELEMENT AND METHOD FOR PRODUCING THE SAME
EP2498964A4 (en) PROCESS FOR PRODUCING GRANULES
EG26633A (en) Process to produce granules
GB0922333D0 (en) Granulate, process for the production of use thereof
EP2386592A4 (en) MANUFACTURING METHOD FOR MASTERBATCH, MASTERBATCH AND USE
IL218348A0 (en) Process and catalyst